Your browser doesn't support javascript.
loading
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients.
Wenzel, Mike; Würnschimmel, Christoph; Chierigo, Francesco; Tian, Zhe; Shariat, Shahrokh F; Terrone, Carlo; Saad, Fred; Tilki, Derya; Graefen, Markus; Roos, Frederik C; A Kluth, Luis; Mandel, Philipp; Chun, Felix K H; Karakiewicz, Pierre I.
Afiliación
  • Wenzel M; Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Würnschimmel C; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Chierigo F; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Tian Z; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Shariat SF; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Terrone C; Department of Urology, Policlinico San Martino Hospital, University of Genova, Genova, Italy.
  • Saad F; Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada.
  • Tilki D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Graefen M; Departments of Urology, Weill Cornell Medical College, New York, New York, USA.
  • Roos FC; Department of Urology, University of Texas Southwestern, Dallas, Texas, USA.
  • A Kluth L; Department of Urology, Second Faculty of Medicine, Charles University, Prag, Czech Republic.
  • Mandel P; Department of Urology, Institute for Urology and Reproductive Health, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • Chun FKH; Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan.
  • Karakiewicz PI; Department of Urology, Policlinico San Martino Hospital, University of Genova, Genova, Italy.
Prostate ; 81(14): 1055-1063, 2021 10.
Article en En | MEDLINE | ID: mdl-34312910
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Adenocarcinoma Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Adenocarcinoma Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2021 Tipo del documento: Article País de afiliación: Alemania